Launch of domestic tetravalent influenza vaccine for all the age groups over 3
A tetravalent cell-cultured influenza vaccine which can be administered in the entire age group over 3 will be launched in Korea for the first time in the world.
On the 23rd, SK Chemicals(CEO Man-hoon Park) announced the launch of the tetravalent cell-cultured influenza vaccine ‘Sky Cellflu Quad...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
